|
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial |
|
|
|
Titel: |
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial |
Auteur: |
Cevik, Muge Thompson, Lindsay C Upton, Caryn Rolla, Valéria Cavalcanti Malahleha, Mookho Mmbaga, Blandina Ngubane, Nosipho Abu Bakar, Zamzurina Rassool, Mohammed Variava, Ebrahim Dawson, Rodney Staples, Suzanne Lalloo, Umesh Louw, Cheryl Conradie, Francesca Eristavi, Marika Samoilova, Anastasia Skornyakov, Sergey N Ntinginya, Niyanda Elias Haraka, Frederick Praygod, George Mayanja-Kizza, Harriett Caoili, Janice Balanag, Vincent Dalcolmo, Margareth Pretti McHugh, Timothy Hunt, Robert Solanki, Priya Bateson, Anna Crook, Angela M Fabiane, Stella Timm, Juliano Sun, Eugene Spigelman, Melvin Sloan, Derek J Gillespie, Stephen H |
Verschenen in: |
The lancet infectious diseases |
Paginering: |
Jaargang 24 () nr. 9 pagina's 1003-1014 |
Jaar: |
2024 |
Inhoud: |
|
Uitgever: |
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC 4.0 license |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|